NHS National Framework for Lenvatinib

Project title: NHS National Framework for Lenvatinib

Offer reference number: CM/TNS/26/5751

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.

CM/TNS/26/5751 Lenvatinib

Lot 1 CESW: 01/06/2027 to 31/01/2029 (20 months)

Lot 2 NWLN: 01/06/2027 to 30/09/2028 (16 months)

Lot 3 LSNE: 01/06/2027 to 31/05/2028 (12 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England